organization · Reporting owner

VARIAN MEDICAL SYSTEMS INC

Disclosed activity across 2 companies

Tapewire entity: 140252
SEC CIK: 0000203527

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Fusion Pharmaceuticals Inc.

Report date June 30, 2020 · Filed July 02, 2020

Section 16 reporting ended · disclosed 2020-07-02. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common SharesSEC Table I · non-derivative	Direct	3,218,632	Ending reported balance After 2020-06-30 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2020-06-30 · Conversion · Acquired 499,468 · Balance 499,468 F1: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. Row 2 · 2020-06-30 · Conversion · Acquired 2,719,164 · Balance 3,218,632 F2: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares.
Class A Preferred SharesSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2020-06-30 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2020-06-30 · Conversion · Disposed 2,666,667 · Balance 0 F1: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares.
Class B Preferred SharesSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2020-06-30 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2020-06-30 · Conversion · Disposed 14,517,619 · Balance 0 F2: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares.

Filing footnotes · ownership attribution and instrument terms

F1: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares.

F2: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares.

Varex Imaging Corp

Report date January 28, 2017 · Filed January 31, 2017

Section 16 reporting ended · disclosed 2017-01-31. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2017-01-28 transaction · row 1 1 source row Row 1 · 2017-01-28 · Other · Disposed 37,386,730 · Balance 0 F1: The reporting person distributed such shares of Varex Imaging Corporation common stock to its stockholders on a pro rata basis. F2: This Form 4 is being filed in connection with the separation of Varex Imaging Corporation from Varian Medical Systems, Inc. Prior to the distribution reported hereunder, the 100 shares of Varex Imaging Corporation's Common Stock that were previously held by Varian Medical Systems Inc. were subdivided and converted into a number of shares of validly issued, fully paid and non-assessable shares of Varex Imaging Corporation Common Stock equal to the number of shares of common stock, par value $1.00, of Varian Medical Systems, Inc. that were issued and outstanding as of the effective time of the distribution transaction, divided by two hundred fifty (250).

Filing footnotes · ownership attribution and instrument terms

F1: The reporting person distributed such shares of Varex Imaging Corporation common stock to its stockholders on a pro rata basis.

F2: This Form 4 is being filed in connection with the separation of Varex Imaging Corporation from Varian Medical Systems, Inc. Prior to the distribution reported hereunder, the 100 shares of Varex Imaging Corporation's Common Stock that were previously held by Varian Medical Systems Inc. were subdivided and converted into a number of shares of validly issued, fully paid and non-assessable shares of Varex Imaging Corporation Common Stock equal to the number of shares of common stock, par value $1.00, of Varian Medical Systems, Inc. that were issued and outstanding as of the effective time of the distribution transaction, divided by two hundred fifty (250).

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 30, 2020 Filed Jul 2, 2020 16:02 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass B Preferred Shares · Derivative	14,517,619	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018255 · doc4.xml · derivative · entry 4 VARIAN MEDICAL SYSTEMS INC · CIK 0000203527 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,719,164 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F2 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F2 · derivative.exercise_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F2 · derivative.expiration_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:02 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass A Preferred Shares · Derivative	2,666,667	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018255 · doc4.xml · derivative · entry 3 VARIAN MEDICAL SYSTEMS INC · CIK 0000203527 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 499,468 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.exercise_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.expiration_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:02 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	2,719,164	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018255 · doc4.xml · nonDerivative · entry 2 VARIAN MEDICAL SYSTEMS INC · CIK 0000203527 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:02 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	499,468	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018255 · doc4.xml · nonDerivative · entry 1 VARIAN MEDICAL SYSTEMS INC · CIK 0000203527 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:12 UTC	Varex Imaging Corp VREX · Entity 5135	OtherCommon Stock	37,386,730	$0.00	$0.00	Disclosure SEC source: 0001209191-17-006528 · doc4.xml · nonDerivative · entry 1 VARIAN MEDICAL SYSTEMS INC · CIK 0000203527 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reporting person distributed such shares of Varex Imaging Corporation common stock to its stockholders on a pro rata basis. F2 · shares: This Form 4 is being filed in connection with the separation of Varex Imaging Corporation from Varian Medical Systems, Inc. Prior to the distribution reported hereunder, the 100 shares of Varex Imaging Corporation's Common Stock that were previously held by Varian Medical Systems Inc. were subdivided and converted into a number of shares of validly issued, fully paid and non-assessable shares of Varex Imaging Corporation Common Stock equal to the number of shares of common stock, par value $1.00, of Varian Medical Systems, Inc. that were issued and outstanding as of the effective time of the distribution transaction, divided by two hundred fifty (250). Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.